IMCR Immunocore Holdings: Multiplikator nilai perusahaan marang pendapatan

Logo perusahaan publik immunocore.com (IMCR)

Immunocore Holdings plc (IMCR) is implementing laboratory screening automation to accelerate drug development. Stable demand for the treatment of rare tumors ensures high margins for its patented products. Comparing the company's price-to-sales ratio on GURU.Markets, we see the impact of Kimmtrak sales and new molecules; meanwhile, 2119.66 determines this parameter level, confirming the market valuation of TCR therapy's potential.

Nilai perusahaan marang pendapatan: Immunocore Holdings (IMCR) kanggo 23.11.2025 - 20.11.2026

immunocore.com - rincian analitis lan metrik utama (IMCR)

- rega saham lan konsensus proyeksi valuasi:
- informasi babagan dhuwit lan arus kas:
Analisis wiwitan perusahaan:Immunocore Holdings plc IMCR
Sampel barang Immunocore Holdings plc

The EV/Sales multiple determines the market value of a business relative to its revenue, excluding the impact of debt load to provide an objective assessment of operational efficiency. This metric measures the density of investor expectations by filtering out the statistical noise of daily fluctuations. For Immunocore Holdings plc (IMCR), which develops immunotherapy through research alliances without capital mergers, the EV/Sales multiple reflects the value of pure organic growth. Analysis of the chart's dynamics allows for the identification of the risk of sharp drawdowns when the price deviates from the norm. This is a critical indicator of capital stability during the technological development phase.

Analisis pesaing Immunocore Holdings plc

IBRX (immunitybio.com) - Rasio nilai perusahaan marang pendapatan|Janux Corp (JANX) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Arcus Bio (RCUS)|Nilai perusahaan marang pendapatan ZYME|TNGX - Rasio nilai perusahaan marang dodolan|Nilai perusahaan marang pendapatan IOVA (Iovance)|Koefisien nilai perusahaan marang pendapatan IMTX|Multiplikator EV/Sales XNCR (Xencor)|Nilai bisnis marang pendapatan CMPX|replimune.com - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Lyell Pharma|Innate Pharma S.A. (IPHA) - Rasio nilai perusahaan marang pendapatan|Pyxis Oncology Inc. - Nilai bisnis marang pendapatan|CGEN (Compugen Limited) - Multiplikator EV/Sales|Multiplikator EV/Sales IO Biotech Inc|Rasio nilai perusahaan marang pendapatan Sutro Biopharma (STRO)|INKT: Nilai perusahaan marang volume dodolan|Werewolf Therapeutics, Inc. - Nilai perusahaan marang pendapatan|Immix (IMMX) - Multiplikator nilai perusahaan marang pendapatan|ALX Oncology Holdings Inc. - Multiplikator EV/Sales|CUE - Multiplikator EV/Sales|PDSB: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Sonnet BioTherapeutics Holdings Inc. (SONN)|MAIA (MAIABiotech.com) - Multiplikator EV/Sales|Nilai perusahaan marang pendapatan Liminatus Pharma (LIMN)|Multiplikator EV/Sales LVTX|Koefisien nilai perusahaan marang pendapatan NXTC|Leap Therapeutics, Inc. - Nilai perusahaan marang pendapatan|INTS: Rasio nilai perusahaan marang pendapatan|Sensei Biotherapeutics Inc - Multiplikator EV/Sales|TOVX: Rasio nilai perusahaan marang pendapatan|gritstonebio.com (GRTS) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan KA|Rasio nilai perusahaan marang pendapatan NexImmune, Inc.|Rasio nilai perusahaan marang pendapatan TSBX (Turnstone Biologics)|Nilai perusahaan marang pendapatan VCNX (Vaccinex, Inc.)|Koefisien nilai perusahaan marang pendapatan HARP